Amgen (AMGN) Return on Invested Capital (2009 - 2026)

Amgen's Return on Invested Capital history runs 17 years deep, the most recent figure standing at 0.01% for Q1 2026.

• In Q1 2026, Return on Invested Capital changed 0.0% year-over-year to 0.01%; the TTM figure through Mar 2026 stood at 0.01% (changed 0.0% YoY), while the FY2025 annual figure was 0.02%, down 1.0% from the prior year.
• Return on Invested Capital for Q1 2026 stood at 0.01%, up from 0.01% in the prior quarter.
• The five-year high for Return on Invested Capital was 0.02% in Q4 2022, with the low at 0.0% in Q1 2025.
• The 5-year median for Return on Invested Capital is 0.01% (2022), against an average of 0.01%.
• Peak annual rise in Return on Invested Capital reached 1 bps in 2022, while the deepest fall reached 3 bps in 2022.
• Amgen's Return on Invested Capital stood at 0.02% in 2022, then sank by 46 bps to 0.01% in 2023, then tumbled by 63 bps to 0.0% in 2024, then soared by 56 bps to 0.01% in 2025, then gained by 3 bps to 0.01% in 2026.
• Business Quant data shows AMGN's Return on Invested Capital at 0.01% in Q1 2026, 0.01% in Q4 2025, and 0.01% in Q3 2025.